This provider's $3.4M in total Medicare payments ranks in the 98th percentile of Diagnostic Radiology providers nationally.
Medicare payments to this provider grew 3704% from 2017 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 994% in 2021
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2017 | $191.39 | $95.27 | 2.01x | $96.12 | $34.2K | 399 | 399 |
| 2018 | $346.43 | $69.99 | 4.95x | $276.44 | $57.3K | 956 | 947 |
| 2019 | $85.73 | $63.83 | 1.34x | $21.90 | $70.1K | 1.4K | 1.4K |
| 2020 | $97.81 | $61.99 | 1.58x | $35.82 | $63.2K | 1.3K | 1.3K |
| 2021 | $872.85 | $457.28 | 1.91x | $415.57 | $691.6K | 1.5K | 1.5K |
| 2022 | $2.2K | $587.56 | 3.76x | $1.6K | $1.2M | 2.0K | 1.9K |
| 2023 | $2.3K | $394.97 | 5.85x | $1.9K | $1.3M | 2.4K | 2.2K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 2.4K | $1.6M | $643.35 | 4.83x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1.3K | $534.3K | $409.10 | 2.06x |
| 78816 | Nuclear medicine study with CT imaging whole body | 365 | $342.7K | $939.02 | 5.09x |
| A9584 | Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | 78 | $166.4K | $2.1K | 2.96x |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | 608 | $156.8K | $257.90 | 6.17x |
| A9515 | Choline c-11, diagnostic, per study dose up to 20 millicuries | 31 | $136.2K | $4.4K | 1.56x |
| 78830 | Spect nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, with concurrently acquired ct transmission scan, 1 day of imaging | 360 | $118.4K | $328.93 | 8.42x |
| A9800 | Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie | 81 | $55.8K | $689.50 | 1.96x |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 485 | $44.1K | $90.96 | 5.50x |
| 78306 | Bone and/or joint imaging, whole body | 266 | $41.0K | $154.12 | 6.45x |
| 78832 | Nuclear medicine study, spect imaging with concurrent ct scan, at least 2 areas or separate acquisitions, single day imaging, or single area or acquisition over multiple days | 30 | $19.1K | $635.49 | 10.93x |
| 78608 | Nuclear medicine study brain with metabolic evaluation | 76 | $17.7K | $232.62 | 6.25x |
| 77080 | Bone density measurement using dedicated X-ray machine | 1.5K | $17.3K | $11.29 | 2.87x |
| 74177 | CT scan of abdomen and pelvis with contrast | 159 | $16.1K | $101.54 | 1.77x |
| A9562 | Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | 30 | $15.8K | $527.32 | 2.34x |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 406 | $15.6K | $38.36 | 13.82x |
| 77012 | Radiological supervision and interpretation of CT guidance for needle insertion | 288 | $15.3K | $53.06 | 3.20x |
| 49406 | Fluid collection drainage by catheter using imaging guidance, accessed through the skin | 61 | $9.0K | $147.32 | 5.51x |
| 78582 | Nuclear medicine study of lung ventilation and blood circulation in the lungs | 49 | $8.3K | $170.04 | 7.56x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 19 | $8.2K | $432.95 | 1.92x |
This provider submits charges 4.41 times higher than what Medicare actually pays.
A markup ratio of 4.41x means for every $100 Medicare pays, this provider initially charges $441. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data